Fundz

Who to call at Lynk Pharmaceuticals, and when

Fundz watches for the moments Lynk Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Lynk Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lynk Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lynk Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Lynk Pharmaceuticals and Simcere Expand Partnership for Zemprocitinib Commercialization in Greater China.

Nov 03, 2026

Contract Type

partnership

HangzhouBiotechnologyHealth CareScience And Engineering

Description

Lynk Pharmaceuticals has expanded its partnership with Simcere Pharmaceutical Group for the commercialization of zemprocitinib, targeting atopic dermatitis in Greater China. This agreement grants Simcere exclusive rights across mainland China, Hong Kong, Macau, and Taiwan, building on their previous collaboration. The expanded partnership aims to enhance market development and patient access to the drug.

Quick answer

Lynk Pharmaceuticals and Simcere Expand Partnership for Zemprocitinib Commercialization in Greater China. (November 3, 2026). Lynk Pharmaceuticals is based in Hangzhou, Zhejiang, China.

What agreement did Lynk Pharmaceuticals announce on November 3, 2026?
Lynk Pharmaceuticals has expanded its partnership with Simcere Pharmaceutical Group for the commercialization of zemprocitinib, targeting atopic dermatitis in Greater China. This agreement grants Simcere exclusive rights across mainland China, Hong Kong, Macau, and Taiwan, building on their previous collaboration.
What does Lynk Pharmaceuticals do?
Lynk Pharmaceuticals, a clinical stage company, was founded in 2018 by senior drug R&D experts and executives from Pfizer, Merck and Johnson & Johnson.
Where is Lynk Pharmaceuticals based?
Lynk Pharmaceuticals is based in Hangzhou, Zhejiang, China.
Which similar companies announced agreements around the same time?
AbbVie Inc. (November 3, 2026), Teva Pharmaceutical Industries Ltd (November 3, 2026), Fresenius SE & KGaA (November 3, 2026) and Aarvik Therapeutics (November 3, 2026) also announced agreements within 45 days of Lynk Pharmaceuticals.

Source: Fundz verified event record.

Other recent agreements in Science And Engineering and Biotechnology

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Lynk Pharmaceuticals

Location

Hangzhou, Zhejiang, China

About

Lynk Pharmaceuticals, a clinical stage company, was founded in 2018 by senior drug R&D experts and executives from Pfizer, Merck and Johnson & Johnson. Lynk Pharmaceuticals is dedicated to the discovery and development of innovative drugs for the treatment of cancer, as well as immune and inflammatory diseases. Driven by a higher goal, Lynk Pharmaceuticals aims to be a market leader to address unmet medical demands by the development of innovative therapies. To date, Lynk Pharmaceuticals has independently developed a number of Class I clinical innovative new drugs, and independently as well as jointly with its US partner launched a number of clinical studies globally. For more information about Lynk Pharmaceuticals, please visit: https://www.lynkpharma.com.

Predictive Intelligence
Strategic

ML-powered predictions for Lynk Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Lynk Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.